@Book{844202401,
author="Le, Tuan Anh",
title="efficacy of concurrent chemoradiation for locally advanced non-small cell lung cancer prospectively treated at Cho Ray hospital, Vietnam, from 3/2009 to 3/2012",
year="2013",
abstract="From 1/3/2009 to 1/3/2012, 1158 patients were diagnosed of lung cancers at Cho Ray hospital, included adenocarcinoma (64.3{\%}), squamous cell carcinoma (11.3{\%}), small cell (4.9{\%}) and others. In NSCLC, 38.4{\%} were in stage III and 60 (14.2{\%})were selected to receive weekly Paclitaxel--Carboplatin concurrently with chest radiotherapy. Common severe toxicities included esophagitis (23.3{\%}) and fatigue (23.3{\%}). Response rate was 57.2{\%}; median of overall and progression-free survival were 14.4 and 10.8 months. Pretreatment performance status and weight loss were two only significant prognostic factors.",
note="vorgelegt von Le Tuan Anh",
note="Rostock, Univ., Med. Fak., Diss., 2014",
url="http://rosdok.uni-rostock.de/resolve?urn=urn:nbn:de:gbv:28-diss2015-0219-2",
url="http://rosdok.uni-rostock.de/resolve?urn=urn:nbn:de:gbv:28-diss2015-0219-2&pdf",
url="http://nbn-resolving.de/urn:nbn:de:gbv:28-diss2015-0219-2",
language="English"
}